Article info
Basic and translational research
Extended report
Aryl hydrocarbon receptor antagonism mitigates cytokine-mediated inflammatory signalling in primary human fibroblast-like synoviocytes
- Correspondence to Dr Gary H Perdew, Department of Veterinary and Biomedical Sciences, Center for Molecular Toxicology and Carcinogenesis, The Pennsylvania State University, 309A Life Sciences Building, University Park, PA 16802, USA; ghp2{at}psu.edu
Citation
Aryl hydrocarbon receptor antagonism mitigates cytokine-mediated inflammatory signalling in primary human fibroblast-like synoviocytes
Publication history
- Received September 7, 2012
- Revised November 9, 2012
- Accepted December 21, 2012
- First published January 24, 2013.
Online issue publication
September 04, 2013
Article Versions
- Previous version (24 January 2013).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions